Free Trial
OTCMKTS:ETBI

Eastgate Biotech (ETBI) Stock Price, News & Analysis

$0.0090
0.00 (0.00%)
(As of 05/22/2024 ET)
Today's Range
$0.0090
$0.0090
50-Day Range
$0.0070
$0.0090
52-Week Range
$0.0001
$0.01
Volume
N/A
Average Volume
299,225 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ETBI stock logo

About Eastgate Biotech Stock (OTCMKTS:ETBI)

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.

ETBI Stock Price History

ETBI Stock News Headlines

EVAX Evaxion Biotech A/S
Best Biotech Stocks Right Now
Coral Academy Eastgate
Eastgate Nursing & Rehabilitation Center
The Seven Deadly Sins of Biotech Investing
Novotech is Gold Sponsor at Biotech Showcase 2023
Eastgate Biotech Corp
See More Headlines
Receive ETBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eastgate Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:ETBI
Previous Symbol
OTCMKTS:ESAQ
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Ms. Rosella C. Perri (Age 56)
    CEO, Secretary, Treasurer & Director
  • Mr. William D. Abajian (Age 66)
    Vice Chairman, President & COO
  • Dr. Joseph Schwarz Ph.D. (Age 68)
    Chief Scientific Officer

ETBI Stock Analysis - Frequently Asked Questions

How have ETBI shares performed in 2024?

Eastgate Biotech's stock was trading at $0.01 on January 1st, 2024. Since then, ETBI shares have decreased by 10.0% and is now trading at $0.0090.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Eastgate Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eastgate Biotech investors own include Delcath Systems (DCTHD), Cassava Sciences (SAVA), Broadcom (AVGO), Exelixis (EXEL), Immunomedics (IMMU), JPMorgan Chase & Co. (JPM), NeoGenomics (NEO), Nokia Oyj (NOK) and PagSeguro Digital (PAGS).

How do I buy shares of Eastgate Biotech?

Shares of ETBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ETBI) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners